Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 69

1.

Measuring the Cost Effectiveness of HIV Prevention Interventions in the US: Pitfalls and Problems.

Hellinger FJ.

Appl Health Econ Health Policy. 2015 Apr;13(2):129-33. doi: 10.1007/s40258-015-0158-5. No abstract available.

PMID:
25724918
2.

Assessing the cost effectiveness of pre-exposure prophylaxis for HIV prevention in the US.

Hellinger FJ.

Pharmacoeconomics. 2013 Dec;31(12):1091-104. doi: 10.1007/s40273-013-0111-0. Review.

PMID:
24271858
3.

What Happens After a Patient Safety Event? Medical Expenditures and Outcomes in Medicare.

Encinosa WE, Hellinger FJ.

In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in Patient Safety: From Research to Implementation (Volume 1: Research Findings). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Feb.

4.

Contemporary costs of HIV healthcare in the HAART era.

Gebo KA, Fleishman JA, Conviser R, Hellinger J, Hellinger FJ, Josephs JS, Keiser P, Gaist P, Moore RD; HIV Research Network.

AIDS. 2010 Nov 13;24(17):2705-15. doi: 10.1097/QAD.0b013e32833f3c14.

5.

The cost and incidence of prescribing errors among privately insured HIV patients.

Hellinger FJ, Encinosa WE.

Pharmacoeconomics. 2010;28(1):23-34. doi: 10.2165/11313810-000000000-00000.

PMID:
20014874
6.
7.

Tax-exempt hospitals and community benefits: a review of state reporting requirements.

Hellinger FJ.

J Health Polit Policy Law. 2009 Feb;34(1):37-61. doi: 10.1215/03616878-2008-991.

PMID:
19234293
8.

The impact of medical errors on ninety-day costs and outcomes: an examination of surgical patients.

Encinosa WE, Hellinger FJ.

Health Serv Res. 2008 Dec;43(6):2067-85. doi: 10.1111/j.1475-6773.2008.00882.x. Epub 2008 Jul 25.

9.

The changing pattern of hospital care for persons living with HIV: 2000 through 2004.

Hellinger FJ.

J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):239-46.

PMID:
17414928
10.

The impact of state laws limiting malpractice damage awards on health care expenditures.

Hellinger FJ, Encinosa WE.

Am J Public Health. 2006 Aug;96(8):1375-81. Epub 2006 Jun 29.

11.

Economic models of antiretroviral therapy: searching for the optimal strategy.

Hellinger FJ.

Pharmacoeconomics. 2006;24(7):631-42. Review.

PMID:
16802839
12.

Inappropriate drug combinations among privately insured patients with HIV disease.

Hellinger FJ, Encinosa WE.

Med Care. 2005 Sep;43(9 Suppl):III53-62.

PMID:
16116309
13.

The delivery of health care services to persons with HIV disease: new empirical studies.

Hellinger FJ.

Med Care. 2005 Sep;43(9 Suppl):III1-2. No abstract available.

PMID:
16116303
14.

Commentary--assessing the impact of managed care patient protection laws: problems and pitfalls.

Hellinger FJ.

Health Serv Res. 2005 Jun;40(3):669-74. No abstract available.

15.

Have state caps on malpractice awards increased the supply of physicians?

Encinosa WE, Hellinger FJ.

Health Aff (Millwood). 2005 Jan-Jun;Suppl Web Exclusives:W5-250-W5-258.

16.

Health plan liability and ERISA: the expanding scope of state legislation.

Hellinger FJ, Young GJ.

Am J Public Health. 2005 Feb;95(2):217-23.

17.

Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.

Gebo KA, Fleishman JA, Conviser R, Reilly ED, Korthuis PT, Moore RD, Hellinger J, Keiser P, Rubin HR, Crane L, Hellinger FJ, Mathews WC; HIV Research Network.

J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):96-103.

PMID:
15608532
18.
19.

HIV patients in the HCUP database: a study of hospital utilization and costs.

Hellinger FJ.

Inquiry. 2004 Spring;41(1):95-105.

PMID:
15224963
20.

Location, race, and hospital care for AIDS patients: an analysis of 10 states.

Hellinger FJ, Fleishman JA.

Inquiry. 2001 Fall;38(3):319-30.

PMID:
11761360
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk